Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LIPG | Q9Y5X9 | 1/20 | 0.45 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.44 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.44 |
| ▸ | PPARA | Q07869 | 3/20 | 0.43 |
| ▸ | BID | P55957 | 5/20 | 0.42 |
| ▸ | MCL1 | Q07820 | 5/20 | 0.42 |
| ▸ | BCL2L1 | Q07817 | 4/20 | 0.42 |
| ▸ | BAK1 | Q16611 | 4/20 | 0.42 |
| ▸ | KAT8 | Q9H7Z6 | 2/20 | 0.42 |
| ▸ | PPARG | P37231 | 2/20 | 0.42 |
| ▸ | SAE1 | Q9UBE0 | 2/20 | 0.42 |
| ▸ | EP300 | Q09472 | 1/20 | 0.42 |
| ▸ | KAT2A | Q92830 | 1/20 | 0.42 |
| ▸ | KAT2B | Q92831 | 1/20 | 0.42 |
| ▸ | KAT5 | Q92993 | 1/20 | 0.42 |
| ▸ | THRA | P10827 | 1/20 | 0.42 |
| ▸ | THRB | P10828 | 1/20 | 0.42 |
| ▸ | CA1 | P00915 | 1/20 | 0.41 |
| ▸ | CA2 | P00918 | 1/20 | 0.41 |
| ▸ | F7 | P08709 | 3/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28321749 | 0.85 | PPARA (0.49) | LIPGALOX5PTGS2PPARABID | |
| SCHEMBL5223765 | 0.81 | CA1 (0.51) | LIPGALOX5PTGS2PPARABID | |
| SCHEMBL27775346 | 0.80 | GAA (0.41) | LIPGALOX5PTGS2PPARGCA1 | |
| SCHEMBL1527091 | 0.80 | ALOX5 (0.55) | LIPGALOX5PTGS2PPARABID | |
| SCHEMBL8119443 | 0.79 | LMNA (0.45) | LIPGPPARACA1CA2 | |
| SCHEMBL617128 | 0.79 | LIPG (0.55) | LIPGALOX5PTGS2PPARABID | |
| SCHEMBL6910210 | 0.78 | ALOX5 (0.54) | LIPGALOX5PTGS2PPARABID | |
| SCHEMBL11503688 | 0.78 | ALOX5 (0.54) | LIPGALOX5PTGS2PPARABID | |
| SCHEMBL8531468 | 0.78 | ALOX5 (0.54) | LIPGALOX5PTGS2PPARABID | |
| SCHEMBL1527072 | 0.78 | ALOX5 (0.54) | LIPGALOX5PTGS2PPARABID |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10259767-B2 | Method for the preparation of alkylsalicylaldehyde and alkylsalicylaldoxime, and use thereof | S.P.C.M. SA (FR) | 2019-04-16 | — | — | US | disclosed |
| US-20180186714-A1 | METHOD FOR THE PREPARATION OF ALKYLSALICYLALDEHYDE AND ALKYLSALICYLALDOXIME, AND USE THEREOF | S.P.C.M. SA (FR) | 2018-07-05 | — | — | US | disclosed |
| EP-3121161-B1 | A METHOD FOR THE PREPARATION OF ALKYLSALICYLALDEHYDE AND ALKYLSALICYLALDOXIME, AND USE THEREOF | SPCM SA (FR) | 2018-03-07 | — | — | EP | disclosed |
| WO-2017012757-A1 | A METHOD FOR THE PREPARATION OF ALKYLSALICYLALDEHYDE AND ALKYLSALICYLALDOXIME, AND USE THEREOF | S.P.C.M. SA (FR) | 2017-01-26 | — | — | WO | disclosed |
| EP-3121161-A1 | A METHOD FOR THE PREPARATION OF ALKYLSALICYLALDEHYDE AND ALKYLSALICYLALDOXIME, AND USE THEREOF | S.P.C.M. SA (FR) | 2017-01-25 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10259767-B2 | Method for the preparation of alkylsalicylaldehyde and alkylsalicylaldoxime, and use thereof | AADAT, HAAO, HNMT | LIPG 4782/4885ALOX5 68/4885PTGS2 60/4885 |
| US-20180186714-A1 | METHOD FOR THE PREPARATION OF ALKYLSALICYLALDEHYDE AND ALKYLSALICYLALDOXIME, AND USE THEREOF | AADAT, HAAO, HNMT | LIPG 4782/4885ALOX5 68/4885PTGS2 60/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.